Evaluation of Online Video Counselling

May 1, 2018 updated by: Swinburne University of Technology
The objective of the study is to establish whether online video counselling is at least equally acceptable and equally as effective to clients and clinicians of the Veterans and Veterans Families Counselling Service (VVCS) as in-person counselling. If this is confirmed by the evaluation then online video counselling can be made more widely available to support the veteran and ex-service community, especially for those who may otherwise be unable to attend therapy and for clients who would prefer such web-based services over in-person sessions.

Study Overview

Study Type

Interventional

Enrollment (Actual)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Victoria
      • Hawthorn, Victoria, Australia, 3029
        • Swinburne University of Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Currently residing in Australia
  • Eligible to receive support from the Veterans and Veterans Families Counselling Service (VVCS)
  • Aged between 18 and 65
  • Home access to broadband internet
  • Own a device (e.g., computer, laptop, or tablet) that has a webcam and can support videoconferencing
  • Be able to reasonably travel to a VVCS centre to access counselling
  • Referred for one-to-one counselling or therapy
  • Be willing and able to receive either modality of treatment (i.e., online or in-person counselling).

Exclusion Criteria:

  • Not currently residing in Australia
  • Not eligible to receive support from VVCS
  • Significant current risk issues or levels of acute distress requiring crisis management
  • Current serving member of the Australian Defence Force with a high security clearance (above Baseline Vetting)
  • Referred for couple or family counselling.
  • Have received a psychiatric diagnosis of post-traumatic stress disorder.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Traditional in-person
Participants randomised to this arm will receive traditional in-person counselling (i.e., treatment will be conducted with the client and clinician occupying the same physical location/room)
Traditional in-person counselling is often referred to as "face-to-face" and can be loosely defined as any mental health intervention, whereby the clinician is in the same room with a client. The terms "in-person" and "same room" are used less frequently, but it has been argued that these terms are more descriptive (since in videoconferencing, clients are also seen "face-to-face" on screen). Therefore, the current study uses the term "in-person" to describe traditional, face-to-face counselling.
EXPERIMENTAL: Online counselling
Participants randomised to this arm will receive treatment from a clinician via videoconferencing (i.e., communication between the client and clinician will occur via webcam)
Videoconferencing facilitates communication between individuals (i.e., the counsellor and the client) in different geographical locations enabling them to interact simultaneously with each other on a computer monitor in real time. In other words, both the client and the therapist communicate live using both visual and audio aids simulating in-person therapy albeit from two separate geographical locations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Group x Time Interaction for overall mental health as measured by the K10 from baseline to 16-week follow up
Time Frame: Baseline, 8-week follow-up, 16-week follow-up
0 to 16 week difference in K10 scores in group x time interaction. The Kessler Psychological Distress Scale (K10) (Kessler et al., 2002) is a 10-item questionnaire intended to yield a global measure of distress based on questions about anxiety and depressive symptoms that a person has experienced in the most recent 4-week period.
Baseline, 8-week follow-up, 16-week follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Group x Time Interaction for the Outcome Rating Scale from baseline to 16-week follow up
Time Frame: Baseline, 8-week follow-up, 16-week follow-up
0 to 16 week difference in ORS scores in group x time interaction. The Outcome Rating Scale (ORS, Miller, Duncan, Brown, Sparks, & Claud, 2003) will also be administered at all three time points. This is a 4-item self-report inventory that measures three different dimensions of client functioning generally considered as valid indicators of treatment progress: individual (or symptomatic) functioning, interpersonal relationships, and social role performance (work adjustment, quality of life).
Baseline, 8-week follow-up, 16-week follow-up
Group x Time Interaction for Quality of Life from baseline to 16-week follow up
Time Frame: Baseline, 8-week follow-up, 16-week follow-up (only administered to participants completing the survey online)

0 to 16 week difference in AQoL-8D scores in group x time interaction. The Assessment of Quality of Life-8D (AQoL-8D, Richardson et al., 2014) is a 35-item measure of health related quality of life which is sensitive to mental health issues, and is suitable for calculation of QALYs.

This measure is to be administered at all three data collection points, however, due to the length of this measure, it would be too time consuming for participants to complete this measure over the telephone. Therefore, this measure will only be completed by participants who complete the assessment online.

Baseline, 8-week follow-up, 16-week follow-up (only administered to participants completing the survey online)
Therapeutic (or Working) Alliance
Time Frame: 8-week follow up
The Working Alliance Inventory - Short Revised (WAI-SR). This is a 12-item form of the WAI (Horvath & Greenberg, 1989). It is a self-report inventory that measures the quality of the therapeutic relationship from the client's perspective.
8-week follow up
Client Satisfaction
Time Frame: 8-week follow up
The NHS Friends and Family Test (FFT). This is a single-item measure used to help service providers understand whether their clients are satisfied with the service provided.
8-week follow up
Client and Clinician Experiences
Time Frame: Up to 6 months post-treatment
Semi-structured interviews will also be conducted on clients and clinicians to further investigate their respective experiences with the form of treatment
Up to 6 months post-treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Denny Meyer, Swinburne University of Technology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 26, 2017

Primary Completion (ACTUAL)

April 1, 2018

Study Completion (ACTUAL)

April 1, 2018

Study Registration Dates

First Submitted

December 21, 2016

First Submitted That Met QC Criteria

February 12, 2017

First Posted (ACTUAL)

February 15, 2017

Study Record Updates

Last Update Posted (ACTUAL)

May 4, 2018

Last Update Submitted That Met QC Criteria

May 1, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • OVC-2016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Videoconferencing

Clinical Trials on Traditional in-person counselling

3
Subscribe